David Mayleben

Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder

Russell Rosenberg, Patricia Murphy, Gary Zammit et al. · JAMA Network Open · 2019 · 383 citations · Full text

Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study

Patricia Murphy, Margaret Moline, David Mayleben et al. · Journal of Clinical Sleep Medicine · 2017 · 320 citations · Full text

Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials

Emmanuel Mignot, David Mayleben, Ingo Fietze et al. · The Lancet Neurology · 2022 · 211 citations

Sleep, Psychiatry, Insomnia Disorder +5

Automation cueing modulates cerebral blood flow and vigilance in a simulated air traffic control task

Edward M. Hitchcock, Joel S. Warm, Gerald Matthews et al. · Theoretical Issues in Ergonomics Science · 2003 · 179 citations

Engineering, Safety Science, Situation Awareness +22

Daridorexant, a New Dual Orexin Receptor Antagonist to Treat Insomnia Disorder

Yves Dauvilliers, Gary Zammit, Ingo Fietze et al. · Annals of Neurology · 2020 · 136 citations